Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. DaSilva
Pcn12 - Comparative Analysis of Profiles of Stage Iiib/Iv NSCLC Patients by Time From Diagnosis to First Treatment in Western Europe
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn14 - Comparative Analysis of Profiles of Stage Iiib/Iv NSCLC Patients by Time From Diagnosis to First Treatment in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
P2.01-91 Treatment Patterns in Patients With Stage IIIB-IV NSCLC in Clinical Practice: Retrospective Analysis of a UK Trust Database
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-48 Predictive Factors in NSCLC Patients With Stage IIIB/IV Treated With First Line Platinum-Doublet Chemotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PCN12 Survival Patterns by Line of Treatment of Stage IV Colorectal (CRC) Patients From Local Oncology Practice in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P23 Stage IIIb NSCLC and Curative Intention Treatment: Difficulties and Disparities in Brazil
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Effects of Microwave Ablation or Its Combination With Whole-Body Chemotherapy on Serum Vascular Endothelial Growth Factor Levels in Patients With Stage IIIB/IV NSCLC
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
P3.13-10 Factors Associated With Long-Term Survival of Stage IV NSCLC Patients on First-Line EGFR-Targeting Therapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Efficacy and Safety of First-Line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
JAMA Oncology
Cancer Research
Oncology